1. What Is the Metagenomics Market?
The Metagenomics Market covers shotgun metagenomics sequencing, 16S rRNA amplicon profiling, metaviromics, functional gene annotation pipelines, and clinical infectious disease metagenomics tools. These technologies characterize complex microbial communities without culture from environmental or clinical samples. Applications include gut microbiome research, environmental contamination monitoring, clinical pathogen identification, food safety microbial profiling, and pandemic pathogen surveillance. Market dynamics reflect microbiome drug target discovery investment, clinical metagenomics diagnostic adoption, environmental regulatory monitoring requirements, and pandemic preparedness surveillance program expansion. Long-read metagenomics and real-time nanopore sequencing are advancing clinical infectious disease metagenomics.
2. Metagenomics Market Size & Forecast
3. Emerging Technologies
- Nanopore real-time field metagenomics for outbreak response without laboratory infrastructure are advancing. Growing deployment is driven by pandemic preparedness and agricultural pathogen outbreak response needs.
- Long-read metagenomics enabling complete microbial genome assembly from complex communities are advancing. Growing adoption is driven by mobile genetic element and plasmid AMR gene characterization requirements.
- AI metagenomics taxonomic classifiers trained on expanding reference databases are advancing. Growing use is driven by novel species identification accuracy improvement in clinical specimens.
- Targeted metagenomic capture enrichment methods for low-abundance pathogen detection are advancing. Growing adoption is driven by sensitivity improvement for rare pathogen detection in complex samples.
Such innovations are driving change across adjacent industries too. Discover more in our Sequencer Market.
4. Key Market Opportunity
The primary opportunity in the Metagenomics Market is clinical pathogen-agnostic diagnostic adoption. Gut microbiome drug target metagenomics creates a pharmaceutical research platform revenue opportunity. Wastewater surveillance contracts create recurring public health infrastructure revenue. Asia Pacific metagenomics market expansion in China and Japan creates geographic opportunity.
5. Top Companies in the Metagenomics Market
The following organisations hold leading positions in the Metagenomics Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Illumina (metagenomics library kits)
- Oxford Nanopore (MinION, PromethION)
- Pacific Biosciences (HiFi metagenomics)
- Karius (clinical metagenomics)
- CosmosID
- IDbyDNA (Explify)
- UCSF CLIAHUB
- Zymo Research (ZymoBIOMICS)
- Microba Life Sciences
- Second Genome
6. Market Segmentation
The Metagenomics Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Type | Shotgun Metagenomics 16S rRNA Amplicon Metaviromics Functional Metagenomics |
| By Application | Gut Microbiome Research Clinical Diagnostics Environmental Monitoring Food Safety Surveillance |
| By End User | Academic Research Pharmaceutical Drug Discovery Clinical Labs Environmental Agencies |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Metagenomics Market trajectory over the forecast period:
Clinical Metagenomics Is Advancing Pathogen-Agnostic Diagnosis for Unresolved Infectious Disease.Unbiased shotgun metagenomics sequences all nucleic acids in clinical specimens without targeted enrichment. This detects unexpected pathogens missed by conventional culture and targeted PCR diagnostics. UCSF's CLIAHUB and IDbyDNA platforms provide clinical metagenomics reporting for CSF and plasma. Pathogen-agnostic metagenomics is advancing for critically ill patients with unresolved infectious etiology.
Gut Microbiome Metagenomics Is Revealing Drug-Relevant Microbial Metabolite and Gene Function Data.Shotgun metagenomics identifies microbial gene functions producing neuroactive, immunomodulatory, and metabolic metabolites. These functional profiles link microbiome composition to host disease phenotypes at molecular mechanism level. Pharmaceutical companies use gut metagenomics to identify microbial targets and drug-metabolizing bacterial enzymes. Metagenomics-guided microbiome drug development is driving substantial pharmaceutical investment in the technology.
Wastewater Metagenomics Is Enabling Community-Level Pathogen and AMR Gene Surveillance.Shotgun metagenomics of municipal wastewater detects pathogens, antimicrobial resistance genes, and novel variants. This non-invasive surveillance quantifies population-level pathogen exposure without individual testing. CDC National Wastewater Surveillance System uses metagenomics to complement targeted molecular surveillance. Real-time wastewater metagenomics is advancing as a pandemic preparedness early warning infrastructure.
For related market intelligence, see the Microbiome Sequencing Market.
8. Segmental Analysis
By type, the Shotgun Metagenomics segment dominated the Metagenomics Market in 2025. It provides the most comprehensive functional and taxonomic data for complex microbial community studies. The Clinical Infectious Disease Metagenomics segment is fastest-growing, driven by unresolved infection diagnostic adoption.
9. Regional Analysis
Regional demand patterns across the Metagenomics Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Metagenomics Market in 2025 with a market share of 43.0%. The region leads clinical metagenomics platform development at Karius, IDbyDNA, and CosmosID. NIH-funded microbiome research programs generate large institutional metagenomics sequencing demand. Moreover, CDC national wastewater surveillance program drives public health metagenomics infrastructure investment. In addition, US pharmaceutical microbiome drug discovery programs drive gut metagenomics platform adoption. Clinical platform leadership and research volume sustain North American dominance through the forecast period.
Highest CAGR Region
Asia Pacific is projected to register the highest CAGR of 24.08% in the Metagenomics Market through 2034. China's gut microbiome research investment and clinical infectious disease diagnostics program are accelerating adoption. Japan's established microbiome research programs and pharmaceutical investment create growing metagenomics demand. Moreover, South Korea's national infectious disease surveillance programs drive metagenomics infrastructure development. Research investment and clinical adoption position Asia Pacific for sustained Metagenomics Market outperformance.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Metagenomics Market was valued at USD 1.80 Bn in 2025 and is projected to reach USD 7.51 Bn by 2034, growing at a CAGR of 17.20% over the 2026–2034 forecast period.
The Metagenomics Market is projected to grow at a CAGR of 17.20% from 2026 to 2034.
North America dominated the Metagenomics Market in 2025 with a market share of 43.0%.
The leading companies in the Metagenomics Market include Illumina (metagenomics library kits), Oxford Nanopore (MinION, PromethION), Pacific Biosciences (HiFi metagenomics), Karius (clinical metagenomics), CosmosID, IDbyDNA (Explify), UCSF CLIAHUB, Zymo Research (ZymoBIOMICS), Microba Life Sciences, Second Genome.
Clinical metagenomics is advancing pathogen-agnostic diagnosis for unresolved infectious disease.
By type, the Shotgun Metagenomics segment dominated the Metagenomics Market in 2025.
How to Order
Choose Your Package
Condensed edition of this study for students, researchers and academic institutions.
- Condensed edition of the full study
- For students, researchers & academic institutions
- Valid student ID or institutional email required
- Educational, non-commercial use only
The competitive landscape, including key market participants, company size, market positioning, and comparative competitive standing.
- 15 in-depth company profiles
- Company overview
- Product and brand portfolio mapped per company
- Revenue for the last 3 FYs with key financial metrics
- Segmental revenue and regional revenue breakdown
- Market presence, key geographies & end-use industries
- Recent developments
- Key capabilities, differentiators & strategic positioning
- SWOT Analysis
- 15-company market share analysis
- 2025 market share by company
- Company revenue in USD
- Competitive quadrant positioning
- Product portfolio comparison
The complete forecast model, including every study table, is provided in clean, formula-ready Excel format across 3 segmentation axes. Select the geographic coverage required for your analysis.
- One country, broken out across 3 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Excel workbook
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
- Excel workbook
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 3 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack
- Complete research methodology, assumptions & appendix
TAM/SAM/SOM sizing, M&A target screening, patent & IP analysis, supply-chain resilience mapping, ESG roadmaps and other bespoke strategic work.
- TAM / SAM / SOM sizing
- M&A target screening
- Patent & IP analysis
- Supply-chain resilience mapping
- ESG roadmaps & other bespoke strategic work
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.